PIM2 and Miyoshi myopathy: A preclinical study showed that pim447 is active against pim‐2‐dependent MM cells and tumor enlargement in a mouse subcutaneous tumor model52 by suppressing mTOR‐C1 signaling via TSC2 and inhibiting phosphorylation of the Bcl‐2‐associated death promoter.34